Brief: Acurx Pharmaceuticals, Inc. Announces Reverse Stock Split
31/07/2025 15:12
Acurx Pharmaceuticals Inc ACXP.O: ACURX PHARMACEUTICALS, INC. ANNOUNCES REVERSE STOCK SPLIT ACURX PHARMACEUTICALS INC - APPROVES 1-FOR-20 REVERSE STOCK SPLIT Source text: ID:nPn84Zq4Fa Further company coverage: ACXP.O
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program